Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Nautilus Biotechnology, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 86 | 2 | 81 | −3 |
| Shares | 56.4M | 16.3M | 46.1M | +5.92M (+14.8%) |
| Value | $119.7M | $34.6M | $82.9M | −$2.19M (−2.6%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cercano Management LLC | 7,172,985 | $12.9M | 0.52% |
| Anson Funds Management LP | 449,516 | $809.1K | 0.26% |
| CI Private Wealth, LLC | 45,350 | $81.6K | 0.00% |
| Lake Street Advisors Group, LLC | 40,219 | $72.0K | 0.00% |
| Acadian Asset Management LLC | 38,769 | $69.0K | 0.00% |
| Mariner, LLC | 17,977 | $32.0K | 0.00% |
| Shay Capital LLC | 16,896 | $30.4K | 0.02% |
| UBS Group AG | 14,449 | $26.0K | 0.00% |
| Buckingham Strategic Wealth, LLC | 10,711 | $19.3K | 0.00% |
| Nisa Investment Advisors, LLC | 15 | $0 | 0.00% |
| Massmutual Trust Co FSB | 156 | $0 | 0.00% |
Sold out (14)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Bridger Management, LLC | 413,700 | $877.0K |
| Affinity Asset Advisors, LLC | 372,476 | $790.0K |
| Citadel Advisors LLC | 63,062 | $134.0K |
| Brighton Jones LLC | 43,961 | $93.0K |
| Verition Fund Management LLC | 27,995 | $59.0K |
| Alpine Global Management, LLC | 26,477 | $56.0K |
| HRT Financial LP | 25,278 | $53.0K |
| Bank of Montreal | 15,109 | $33.0K |
| Cubist Systematic Strategies, LLC | 15,577 | $33.0K |
| Jump Financial, LLC | 15,000 | $32.0K |
| CWM, LLC | 320 | $1.00K |
| Parallel Advisors, LLC | 363 | $1.00K |
| Capital Advisors, Ltd. LLC | 186 | $0 |
| Ellevest, Inc. | 193 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 16,298,006 | $34.6M |
| American Portfolios Advisors | 3,440 | $7.29K |